Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta‐analysis

ABSTRACT Objective To explore the outcome in women managed expectantly following the diagnosis of Cesarean scar pregnancy (CSP). Methods An electronic search of MEDLINE, EMBASE and ClinicalTrials.gov databases was performed utilizing combinations of relevant medical subject headings for ‘Cesarean sc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ultrasound in obstetrics & gynecology 2018-02, Vol.51 (2), p.169-175
Hauptverfasser: Calì, G., Timor‐Tritsch, I. E., Palacios‐Jaraquemada, J., Monteaugudo, A., Buca, D., Forlani, F., Familiari, A., Scambia, G., Acharya, G., D'Antonio, F.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:ABSTRACT Objective To explore the outcome in women managed expectantly following the diagnosis of Cesarean scar pregnancy (CSP). Methods An electronic search of MEDLINE, EMBASE and ClinicalTrials.gov databases was performed utilizing combinations of relevant medical subject headings for ‘Cesarean scar pregnancy’ and ‘outcome’. Reference lists of relevant articles and reviews were hand‐searched for additional reports. Observed outcomes included: severe first‐trimester vaginal bleeding; clinical symptoms (abdominal pain, vaginal bleeding) requiring treatment; uncomplicated miscarriage; complicated miscarriage requiring intervention; first‐ or second‐trimester uterine rupture or hysterectomy; third‐trimester bleeding, uterine rupture or hysterectomy; maternal death; incidence of abnormally invasive placenta (AIP); prevalence of placenta percreta; ultrasound signs suggestive of AIP; and live birth. Meta‐analyses of proportions using a random‐effects model were used to combine data. Cases were stratified based on the presence or absence of embryonic/fetal heart activity at the time of diagnosis. Results A total of 17 studies (69 cases of CSP managed expectantly, 52 with and 17 without embryonic/fetal heart beat) were included. In women with CSP and embryonic/fetal heart activity, 13.0% (95% CI, 3.8–26.7%) experienced an uncomplicated miscarriage, while 20.0% (95% CI, 7.1–37.4%) required medical intervention. Uterine rupture during the first or second trimester of pregnancy occurred in 9.9% (95% CI, 2.9–20.4%) of cases, while hysterectomy was required in 15.2% (95% CI, 3.6–32.8%) of all cases. Forty (76.9% (95% CI, 65.4–86.5%)) women progressed to the third trimester of pregnancy, of whom 39.2% (95% CI, 15.4–66.2%) experienced severe bleeding. Finally, 74.8% (95% CI, 52.0–92.1%) had a surgical or pathological diagnosis of AIP at delivery and around two‐thirds (69.7% (95% CI, 42.8–90.1%)) of them had placenta percreta. In women with CSP but no embryonic/fetal cardiac activity, an uncomplicated miscarriage occurred in 69.1% (95% CI, 47.4–87.1%) of cases, while surgical or medical intervention during or immediately after miscarriage was required in 30.9% (95% CI, 12.9–52.6%). Uterine rupture during the first trimester of pregnancy occurred in 13.4% (95% CI, 2.7–30.3%) of cases, but hysterectomy was not required in any case. Conclusions CSP with positive embryonic/fetal heart activity managed expectantly is associated with a high burden of maternal morbidity includi
ISSN:0960-7692
1469-0705
DOI:10.1002/uog.17568